DR ANKUR Ahmad SRIVASTAVA

Dr. DR ANKUR Ahmad SRIVASTAVA

Indian Institute of Toxicology Research, Lucknow, India
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Sadaf JahanSadaf Jahan
Sadaf Jahan
DSDR ANKUR Ahmad SRIVASTAVA
DR ANKUR Ahmad SRIVASTAVA
ARIF SIDDIQUIARIF SIDDIQUI
ARIF SIDDIQUI
DIDanish Iqbal
Danish Iqbal
JKJOHRA KHAN
JOHRA KHAN
APAditya Bhushan Pant
Aditya Bhushan Pant
Environmental exposure to arsenic has been profoundly associated with chronic systemic disorders, such as neurodegeneration, in both experimental models and clinical studies. The neuronal cells of the brain and the nervous system have a limited regeneration capacity, thus making them more vulnerable to exposure to xenobiotics, leading to long-lasting disabilities. The functional and anatomical complexity of these cells hinders the complete understanding of the mechanisms of neurodegeneration and neuroprotection. The present investigations aimed to evaluate the neuroprotective efficacy of a herbal formulation of Nobiletin (NOB) against the toxic insult induced by sodium arsenate (NA) in human neural progenitor cells (hNPCs) derived from human induced pluripotent stem cells (hiPSCs). Prior to the neuroprotective experiments, biologically safe doses of both NOB and NA were ascertained using standard endpoints of cytotoxicity. Thereafter, the hNPCs were exposed to either NOB (50 μM) or NA (50 μM) and co-exposed to biologically safe concentrations of NA (50 μM) with NOB (50 μM) for a period of up to 48 h. NOB treatment restored the morphological damage (neurite damage), the levels of stress granule G3BP1 (Ras-GTPase-activating protein (SH3 domain)-binding protein) and TIA1 (T cell-restricted intracellular antigen), and the expression of neuronal markers (Tuj1, Nestin, MAP2, and PAX6) when compared to NA-exposed cells. A substantial restoration of reactive oxygen species and mitochondrial membrane potential was also witnessed in the co-exposure group (NA + NOB) in comparison to the NA-exposed group. The findings suggest that NOB possesses a significant restorative/protective potential against the NA challenge in hNPCs under experimental conditions and imply that nobiletin may impart a potential therapeutic impact if studied adequately using in vivo studies.


25 March 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DSDR ANKUR Ahmad SRIVASTAVA
DR ANKUR Ahmad SRIVASTAVA
APAnkita Bhushan Srivastava. PhD
Ankita Bhushan Srivastava. PhD
ASANKUR KUMAR SRIVASTAVA
ANKUR KUMAR SRIVASTAVA
APAbhishek Pandeya
Abhishek Pandeya
PVPANKHI VATSA
PANKHI VATSA
APAditya Bhushan Pant
Aditya Bhushan Pant
Background/Objectives: TDP-43 mutation-driven Amyotrophic Lateral Sclerosis (ALS) motor neuron disease is one of the most prominent forms (approximately 97%) in cases of sporadic ALS. Dysfunctional autophagy and lysosomal function are the prime mechanisms behind ALS. Mitoxantrone (Mito), a synthetic doxorubicin analog, is an inhibitor of DNA and RNA synthesis/repair via intercalating with nitrogenous bases and inhibiting topoisomerase II. The therapeutic potential of miRNAs associated with disease conditions has also been reported. This study explores the therapeutic potential of Mito along with miRNAs against mutated TDP-43 protein-induced proteinopathy in human-induced pluripotent stem cell (hiPSC)-derived human neural progenitor cells (hNPCs). Methods: HiPSCs mutated for TDP-43 were differentiated into hNPCs and used to explore the therapeutic potential of Mito at a concentration of 1 μM for 24 h (the identified non-cytotoxic dose). The therapeutic effects of Mito on miRNA expression and various cellular parameters such as mitochondrial dynamics, autophagy, and stress granules were assessed using the high-throughput Open Array technique, immunocytochemistry, flow cytometry, immunoblotting, and mitochondrial bioenergetic assay. Results: Mutated TDP-43 protein accumulation causes stress granule formation (G3BP1), mitochondrial bioenergetic dysfunction, SOD1 accumulation, hyperactivated autophagy, and ER stress in hNPCs. The mutated hNPCs also show dysregulation in six miRNAs (miR-543, miR-34a, miR-200c, miR-22, miR-29b, and miR-29c) in mutated hNPCs. A significant restoration of TDP-43 mutation-induced alterations could be witnessed upon the exposure of mutated hNPCs to Mito. Conclusions: Our study indicates that miR-543, miR-29b, miR-22, miR-200c, and miR-34a have antisense therapeutic potential alone and in combination with Mitoxantrone.

1 January 2026 in Immune Network
Verified
Journal Article
Open access
PDF file
DSDR ANKUR Ahmad SRIVASTAVA
DR ANKUR Ahmad SRIVASTAVA
JWJan Wisniewski
Jan Wisniewski
CMChristian T. Mayer
Christian T. Mayer
Ansari UA, et al. Immune Netw. 2026 Aug;26(4):e33. https://doi.org/10.4110/in.2026.26.e33

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
PVPANKHI VATSA
PANKHI VATSA
RNRenu Negi
Renu Negi
DSDR ANKUR Ahmad SRIVASTAVA
DR ANKUR Ahmad SRIVASTAVA
APAditya Pant
Aditya Pant
VKVinay Kumar Khanna
Vinay Kumar Khanna

28 October 2026 in STAR Protocols
Verified
Journal Article
Open access
MIMichael Ivanov
Michael Ivanov
DSDR ANKUR Ahmad SRIVASTAVA
DR ANKUR Ahmad SRIVASTAVA
JWJan Wisniewski
Jan Wisniewski
CMChristian T. Mayer
Christian T. Mayer